These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Viral particle specific serums, used in complement fixation tests of foot-and-mouth disease virus]. Roumiantzeff M, Fayet MT. Ann Inst Pasteur (Paris); 1969 Jun; 116(6):833-51. PubMed ID: 4312138 [No Abstract] [Full Text] [Related]
4. [Serological study of several strains of foot-and-mouth disease virus type "O" isolated in Europe between 1971 and 1975: application of the biomathematical system of classification]. Moreau Y, Stellmann C, Moussa A, Lombard M. Dev Biol Stand; 1976 Jun; 35():179-84. PubMed ID: 198285 [Abstract] [Full Text] [Related]
5. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates. Bauer K. Dev Biol Stand; 1976 Jun; 35():297-300. PubMed ID: 198299 [Abstract] [Full Text] [Related]
7. Differentiation of type A foot-and-mouth disease virus subtypes by double- and radial-immunodiffusion analysis. Lobo CA, Cowan KM, Trautman R, Hanson RP. Am J Vet Res; 1974 Aug; 35(8):1121-6. PubMed ID: 4368590 [No Abstract] [Full Text] [Related]
9. Three variants of foot-and-mouth disease virus type O: cell culture characteristics and antigenic differences. McVicar JW, Sutmoller P. Am J Vet Res; 1972 Aug; 33(8):1627-33. PubMed ID: 4340052 [No Abstract] [Full Text] [Related]
10. [Study in the Razi Institute of foot-and-mouth disease virus strains isolated in the Middle East from 1962 to 1967. Influence on the control of foot-and-mouth disease]. Rafyi A, Santucci J, Kaveh M, Giraud M, Arshadi M, Gilbert H, Amighi M, Stellmann C, Mastan B, Fontaine J, Aminzadeh M, Roumiantzeff M, Chafyi A, Favre H, Hessami M. Bull Off Int Epizoot; 1968 Aug; 69(1):57-74. PubMed ID: 4301803 [No Abstract] [Full Text] [Related]
12. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus. Kitching RP, Rendle R, Ferris NP. Vaccine; 1988 Oct; 6(5):403-8. PubMed ID: 2848376 [Abstract] [Full Text] [Related]
13. Serological study of type A Indian foot-and-mouth disease virus isolates. Meer Azad H, Srinivasan VA, Crowther JR. Acta Virol; 1995 Sep; 39(4):193-6. PubMed ID: 8825299 [Abstract] [Full Text] [Related]
14. Serological comparison of a type sat 2 foot-and-mouth disease virus isolate from Sudan with other type SAT 2 strains. Abu Elzein EM, Crowther JR. Bull Anim Health Prod Afr; 1979 Dec; 27(4):245-8. PubMed ID: 232850 [No Abstract] [Full Text] [Related]
15. [Efficacy testing of anti-foot-and-mouth disease vaccines in guinea pigs using myotropic strains]. Eissner G, Böhm HO. Dev Biol Stand; 1976 Dec; 35():279-83. PubMed ID: 198295 [No Abstract] [Full Text] [Related]
17. Immunochemical studies of foot and mouth disease. I. Complement fixation reactions with isolated antigenic components. Cowan KM, Trautman R. J Immunol; 1967 Oct; 99(4):729-36. PubMed ID: 4293091 [No Abstract] [Full Text] [Related]
18. [Comparative trial of the immunogenic properties of commercial foot-and-mouth virus strains]. Tekerlekov P, Nikolova E. Vet Med Nauki; 1981 Oct; 18(1):19-26. PubMed ID: 6272473 [Abstract] [Full Text] [Related]
19. [The efficacy of foot and mouth disease vaccines after long- term storage]. Wittmann G. Berl Munch Tierarztl Wochenschr; 1980 Jan 15; 93(2):33-4. PubMed ID: 6248022 [No Abstract] [Full Text] [Related]
20. [Preliminary study of the combination of anti-foot-and-mouth disease and anti-brucellosis vaccines]. Mastan MB, Amighi M, Ardelan A, Bandpay MR, Ebadi A, Farsi J. Dev Biol Stand; 1976 Jan 15; 35():437-43. PubMed ID: 198311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]